Advances and gaps in SARS-CoV-2 infection models
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Preclinical animal models are crucial for understanding COVID-19 variants of concern (VOCs) and evaluating vaccines. Research is advancing these models to better study VOCs, transmission, and immune escape, improving global health strategies.
Area Of Science
- * Infectious disease modeling and preclinical research.
- * Virology and immunology of SARS-CoV-2.
- * Global public health and pandemic response.
Background
- * The global response to Coronavirus Disease 2019 (COVID-19) faces challenges including vaccine inequity and the emergence of SARS-CoV-2 variants of concern (VOCs).
- * Preclinical models, especially animal models, are vital for understanding disease pathogenesis, vaccine efficacy, and therapeutic interventions.
- * The World Health Organization (WHO) COVID-19 modeling expert group (WHO-COM) provides updates on these critical research tools.
Purpose Of The Study
- * To update on the advances in preclinical models for COVID-19 research.
- * To highlight the role of animal models in evaluating SARS-CoV-2 VOCs.
- * To discuss the refinement of animal models for better disease recapitulation.
Main Methods
- * Review and synthesis of current research on animal models for COVID-19.
- * Expert group discussions and consensus building within the WHO-COM.
- * Analysis of how animal models address VOCs, transmission, and immune escape.
Main Results
- * Animal models are essential for assessing the virulence, transmission, and immune escape of SARS-CoV-2 VOCs.
- * Ongoing refinement of animal models aims to better reflect human demographic variables like age and comorbidities.
- * These models are critical for developing and evaluating vaccines and postexposure therapies against emerging variants.
Conclusions
- * Advances in preclinical animal models are crucial for navigating the evolving challenges of the COVID-19 pandemic.
- * Continued development and application of these models will enhance our ability to combat SARS-CoV-2 variants and inform global health strategies.
- * Sophisticated animal models are indispensable for understanding disease dynamics and testing countermeasures.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...